Market Place
Sourcing Support
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise
02 Sep 2025 //
BUSINESSWIRE
Qiagen Sets Conversion Price for New Net Share Convertible Bonds
29 Aug 2025 //
PHARMAWEB
QIAGEN Announces Successful Placement of New Bonds
28 Aug 2025 //
BUSINESSWIRE
QIAGEN Sets Conversion Price of New Convertible Bonds
28 Aug 2025 //
BUSINESSWIRE
QIAGEN Surpasses Q2 2025 Outlook with Robust Growth
05 Aug 2025 //
BUSINESSWIRE
QIAGEN Launches QIAseq xHYB Long Read Panels, Expands Portfolio
22 Jul 2025 //
BUSINESSWIRE
QIAGEN Elects Stephen Rusckowski as Chairman
26 Jun 2025 //
BUSINESSWIRE
QIAGEN, GENCURIX Partner on QIAcuity Digital PCR IVD Assay
18 Jun 2025 //
BUSINESSWIRE
Qiagen, Incyte Team Up on MPN Companion Diagnostics
15 Jun 2025 //
BUSINESSWIRE
Tracer Biotechnologies partners with QIAGEN for MRD Testing
05 Jun 2025 //
BUSINESSWIRE
QIAGEN expands oncology testing with new strategic partnerships
02 Jun 2025 //
BUSINESSWIRE
Qiagen expands digital PCR oncology research with ID Solutions
22 May 2025 //
BUSINESSWIRE
QIAGEN to Propose Annual Cash Dividend at Shareholder Meeting
07 May 2025 //
BUSINESSWIRE
Qiagen exceeds Q1 2025 outlook, plans dividend, $500 mn repurchas
07 May 2025 //
BUSINESSWIRE
QIAGEN plans leadership transition in Supervisory Board
07 May 2025 //
BUSINESSWIRE
Qiagen Expands digital PCR portfolio with Lentivirus solutions
29 Apr 2025 //
CONTRACTPHARMA
Qiagen Expands Digital PCR Portfolio With New Lentivirus Solution
29 Apr 2025 //
BUSINESSWIRE
QIAGEN Enhances Cancer Genomic Profiling at AACR 2025
22 Apr 2025 //
BUSINESSWIRE
Qiagen to Launch Three New Sample Prep Instruments by 2026
15 Apr 2025 //
BUSINESSWIRE
Qiagen to Release Results for Q1 2025 and Hold Webcast
08 Apr 2025 //
BUSINESSWIRE
Qiagen Gets US Nod For Second QIAstat-Dx GI Panel
06 Mar 2025 //
BUSINESSWIRE
QIAGEN Defends QuantiFERON IP in Latent TB Testing
03 Mar 2025 //
BUSINESSWIRE
QIAGEN Strengthens Bioinformatics with New Data Center in Australia
13 Feb 2025 //
BUSINESSWIRE
QIAGEN Details $300M Synthetic Share Repurchase Completion Plan
16 Jan 2025 //
BUSINESSWIRE
Qiagen To Return $300M To Shareholders Via Share Repurchase
12 Jan 2025 //
BUSINESSWIRE
QIAGEN Secures Clearance For QIAstat-Dx Mini GI Care Panel
09 Jan 2025 //
BUSINESSWIRE
QIAGEN Enhances QIAcuity PCR For Advanced Biological Insights
09 Jan 2025 //
BUSINESSWIRE
Qiagen Introduce Tool For Customizing Digital PCR Assays, NGS Panels
30 Nov 2024 //
PHARMABIZ
Qiagen Launches Tools for Customizing PCR Assays & NGS Panels
27 Nov 2024 //
GLOBENEWSWIRE
QIAGEN Partners with McGill to Advance Microbiome Research
12 Nov 2024 //
GLOBENEWSWIRE
Diagnostics firm Qiagen reports rise in third-quarter revenue
07 Nov 2024 //
REUTERS
Qiagen Delivers Solid Q3 2024 Growth, Increases EPS Outlook
06 Nov 2024 //
GLOBENEWSWIRE
Qiagen Receives FDA Clearance for QIAstat-Dx Meningitis Panel
04 Nov 2024 //
GLOBENEWSWIRE
QIAGEN Receives FDA Clearance for QIAstat-Dx Mini Panel
29 Oct 2024 //
GLOBENEWSWIRE
Qiagen to release results for Q3 2024 and hold webcast
10 Oct 2024 //
GLOBENEWSWIRE
Qiagen Expands Automated Liquid Biopsy Portfolio In Oncology
10 Oct 2024 //
GLOBENEWSWIRE
Qiagen Leads Global TB Summit 2024 As Disease Reemerges
08 Oct 2024 //
GLOBENEWSWIRE
QIAGEN Launches QIAcuityDx Digital PCR System For Oncology
30 Sep 2024 //
GLOBENEWSWIRE
Qiagen Receives European IVDR Certification For QIAstat-Dx
26 Sep 2024 //
GLOBENEWSWIRE
PreAnalytiX Launches Urine Liquid Biopsy Solution
25 Sep 2024 //
GLOBENEWSWIRE
QIAGEN Bode Partner On GEDmatch PRO Forensic Database
23 Sep 2024 //
GLOBENEWSWIRE
Qiagen Expands QIAcuity With 100 New Assays
18 Sep 2024 //
GLOBENEWSWIRE
QIAGEN And Bio-Manguinhos Partner For Malaria And Dengue Detection
12 Sep 2024 //
GLOBENEWSWIRE
QIAGEN And Lilly Partner On Alzheimer`s Disease Test Panel
04 Sep 2024 //
GLOBENEWSWIRE
QIAGEN N.V. launches non-US offering of net share settled convertible bonds
03 Sep 2024 //
GLOBENEWSWIRE
QIAGEN Announces Successful Placement of New Convertible Bonds
03 Sep 2024 //
GLOBENEWSWIRE
QIAGEN Announces Conversion Price for New Convertible Bonds
03 Sep 2024 //
GLOBENEWSWIRE
Qiagen, AstraZeneca Expand Diagnostic Partnership To Chronic Diseases
29 Aug 2024 //
FIERCE BIOTECH
QIAGEN Expands QIAstat-Dx Into Precision Medicine For Chronic Diseases
28 Aug 2024 //
GLOBENEWSWIRE
QIAGEN delivers solid performance and exceeds outlook for Q2 2024
31 Jul 2024 //
GLOBENEWSWIRE
QIAGEN to enhance the identification of human remains of Indigenous people
08 Jul 2024 //
GLOBENEWSWIRE
QIAGEN N.V. to release results for Q2 2024 and hold webcast
02 Jul 2024 //
GLOBENEWSWIRE
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB in tuberculosis
27 Jun 2024 //
GLOBENEWSWIRE
QIAGEN Announces 2028 Strategy For Solid Profitable Growth
17 Jun 2024 //
GLOBENEWSWIRE
QIAGEN`s QCI Interpret Accelerates NGS Clinical Reporting Turnaround
13 Jun 2024 //
GLOBENEWSWIRE
QIAGEN Publishes 2023 Sustainability Report On ESG Progress
12 Jun 2024 //
GLOBENEWSWIRE
QIAGEN launches new QIAcuity digital PCR assays for microbial applications
11 Jun 2024 //
GLOBENEWSWIRE
QIAGEN To Discontinue NeuMoDx PCR System, Support Customer Transition
06 Jun 2024 //
GLOBENEWSWIRE
QIAGEN: Digital PCR Assay Tool For QIAcuity, GeneGlobe Customization
05 Jun 2024 //
GLOBENEWSWIRE
QIAGEN Expands Gastrointestinal Syndromic Test Menu In US
03 Jun 2024 //
GLOBENEWSWIRE
